Authors
Binqing Qin, Zichu Fu, Xuanxuan Zou, Senmao Chai, Jingjing Weng, Puqing Wang, Xiaodong Sun, Ming Sang
Published in
Animal models and experimental medicine. Jul 14, 2026. Epub Jul 14, 2026.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of midbrain substantia nigra dopaminergic neurons, resulting in striatal dopamine depletion and motor dysfunction. While this pathological cascade is well-established, its underlying mechanisms remain elusive.
To further investigate the pathological mechanisms of PD, we performed single-cell RNA sequencing of the midbrain and striatum from Hua-Syn (SNCA*A53T) transgenic (A53T) mice as a PD model.
Analysis of 22 865 midbrain and 32 117 striatal cells revealed cell-type-specific risk association. Glial populations (astrocytes, microglia, oligodendrocytes) showed significant enrichment for PD-risk genes. Variance-based clustering identified PD-enriched subclusters exhibiting upregulated inflammatory pathways, apoptotic pathways, proteostasis disruption, glutamatergic signaling dysregulation, and mitochondrial respiratory chain defects. Transcriptional regulation analysis identified genes associated with PD specific activity, including Rorb and Foxc1 in the midbrain and Dbx2 and Klf13 in the striatum. Cell-cell interactions showed that cell-to-cell signaling was enhanced, and the SEMA and CCL neuroinflammatory axes were specifically activated in the PD group.
Our integrative analysis delineates the cellular and molecular architecture of the pathological process triggered by the expression of A53T mutant α-synuclein, and provides a framework for targeted therapeutic development.
PMID:
42447147
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 14
- Comments 0